{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:27:03Z","timestamp":1793028423227,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101106"],"award-info":[{"award-number":["82101106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930023"],"award-info":[{"award-number":["81930023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10753-023-01950-y","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T15:02:46Z","timestamp":1704553366000},"page":"909-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet\u2019s Uveitis and Experimental Autoimmune Uveitis"],"prefix":"10.1007","volume":"47","author":[{"given":"Qingfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"3\u20134","key":"1950_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes, D., et al. 2009. Behcet\u2019s disease\u2013a contemporary review. Journal of Autoimmunity 32 (3\u20134): 178\u2013188.","journal-title":"Journal of Autoimmunity"},{"issue":"11","key":"1950_CR2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/bjo.2008.154476","volume":"93","author":"N Kitaichi","year":"2009","unstructured":"Kitaichi, N., et al. 2009. Low prevalence of juvenile-onset Behcet\u2019s disease with uveitis in East\/South Asian people. British Journal of Ophthalmology 93 (11): 1428\u20131430.","journal-title":"British Journal of Ophthalmology"},{"key":"1950_CR3","doi-asserted-by":"crossref","unstructured":"Lu, A., et al.\u00a02023. Global research status regarding uveitis in the last decade. Ocular Immunology and Inflammation\u00a01\u201310.","DOI":"10.1080\/09273948.2023.2170251"},{"issue":"7","key":"1950_CR4","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"M Ben Ahmed","year":"2004","unstructured":"Ben Ahmed, M., et al. 2004. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet\u2019s disease. Arthritis and Rheumatism 50 (7): 2291\u20132295.","journal-title":"Arthritis and Rheumatism"},{"issue":"4 Suppl 60","key":"1950_CR5","first-page":"S16","volume":"28","author":"J Kim","year":"2010","unstructured":"Kim, J., et al. 2010. Imbalance of Th17 to Th1 cells in Behcet\u2019s disease. Clinical and Experimental Rheumatology 28 (4 Suppl 60): S16\u2013S19.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"1950_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","volume":"80","author":"Z Zhong","year":"2021","unstructured":"Zhong, Z., et al. 2021. Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Progress in Retinal and Eye Research 80: 100866.","journal-title":"Progress in Retinal and Eye Research"},{"key":"1950_CR7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","volume":"10","author":"B Tong","year":"2019","unstructured":"Tong, B., et al. 2019. Immunopathogenesis of Behcet\u2019s disease. Frontiers of Immunology 10: 665.","journal-title":"Immunopathogenesis of Behcet\u2019s disease. Front Immunol"},{"key":"1950_CR8","volume":"107","author":"J Chen","year":"2022","unstructured":"Chen, J., et al. 2022. 7-deacetyl-gedunin suppresses proliferation of human rheumatoid arthritis synovial fibroblast through activation of Nrf2\/ARE signaling. International Immunopharmacology 107: 108557.","journal-title":"International Immunopharmacology"},{"key":"1950_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153926","volume":"97","author":"ER Puppala","year":"2022","unstructured":"Puppala, E.R., et al. 2022. Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4\/NF-kappaB and Keap1\/Nrf2 signaling pathways: A comprehensive study on in-vitro and in-vivo experimental models. Phytomedicine 97: 153926.","journal-title":"Phytomedicine"},{"key":"1950_CR10","volume":"137","author":"X Su","year":"2021","unstructured":"Su, X., et al. 2021. Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62\/Nrf2 signaling. Biomedicine & Pharmacotherapy 137: 111382.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"1950_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.retram.2020.05.002","volume":"68","author":"S Chadha","year":"2020","unstructured":"Chadha, S., et al. 2020. Role of Nrf2 in rheumatoid arthritis. Current Research in Translational Medicine\u00a068 (4): 171\u2013181.","journal-title":"Curr Res Transl Med"},{"key":"1950_CR12","doi-asserted-by":"crossref","unstructured":"Barati, M.T., and D.J. Caster. 2022. The potential of Nrf2 activation as a therapeutic target in systemic lupus erythematosus. Metabolites 12 (2).","DOI":"10.3390\/metabo12020151"},{"issue":"10","key":"1950_CR13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.41383","volume":"72","author":"S Han","year":"2020","unstructured":"Han, S., et al. 2020. NF-E2-related factor 2 regulates interferon receptor expression and alters macrophage polarization in lupus. Arthritis & Rhematology 72 (10): 1707\u20131720.","journal-title":"Arthritis & Rhematology"},{"issue":"2","key":"1950_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152180","volume":"227","author":"P Gautam","year":"2022","unstructured":"Gautam, P., et al. 2022. Proportion of B cell subsets and Nrf2 mediated redox regulation in systemic lupus erythematosus patients. Immunobiology 227 (2): 152180.","journal-title":"Immunobiology"},{"issue":"2","key":"1950_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfp274","volume":"114","author":"DA Johnson","year":"2010","unstructured":"Johnson, D.A., et al. 2010. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicological Sciences 114 (2): 237\u2013246.","journal-title":"Toxicological Sciences"},{"issue":"41","key":"1950_CR16","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1021\/ja2070889","volume":"133","author":"CL Strelko","year":"2011","unstructured":"Strelko, C.L., et al. 2011. Itaconic acid is a mammalian metabolite induced during macrophage activation. Journal of the American Chemical Society 133 (41): 16386\u201316389.","journal-title":"Journal of the American Chemical Society"},{"issue":"7699","key":"1950_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E.L., et al. 2018. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556 (7699): 113\u2013117.","journal-title":"Nature"},{"key":"1950_CR18","doi-asserted-by":"crossref","unstructured":"Runtsch, M.C., et al.\u00a02022. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metabolism 34 (3): 487\u2013501 e8.","DOI":"10.1016\/j.cmet.2022.02.002"},{"key":"1950_CR19","doi-asserted-by":"crossref","unstructured":"Hooftman, A., et al.\u00a02020. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metabolism 32 (3): 468\u2013478 e7.","DOI":"10.1016\/j.cmet.2020.07.016"},{"issue":"2","key":"1950_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41385-021-00462-y","volume":"15","author":"AK Jaiswal","year":"2022","unstructured":"Jaiswal, A.K., et al. 2022. Irg1\/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation. Mucosal Immunology 15 (2): 301\u2013313.","journal-title":"Mucosal Immunology"},{"key":"1950_CR21","doi-asserted-by":"crossref","unstructured":"The International Criteria for Behcet's Disease (ICBD). 2014. a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.\u00a0Journal of the European Academy of Dermatology and\u00a0Venereology\u00a0 28 (3): 338\u201347.","DOI":"10.1111\/jdv.12107"},{"issue":"6","key":"1950_CR22","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.21037\/apm-20-1848","volume":"9","author":"B Hu","year":"2020","unstructured":"Hu, B., et al. 2020. Nuclear factor E2 related factor (NRF2) inhibits mast cell- mediated allergic inflammation via SIRT4-mediated mitochondrial metabolism. Annals of Palliative Medicine\u00a09 (6): 3839\u20133847.","journal-title":"Ann Palliat Med"},{"issue":"9","key":"1950_CR23","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1167\/iovs.15-17280","volume":"56","author":"MJ Mattapallil","year":"2015","unstructured":"Mattapallil, M.J., et al. 2015. Characterization of a new epitope of IRBP that induces moderate to severe uveoretinitis in mice with H-2b haplotype. Investigative Ophthalmology & Visual Science 56 (9): 5439\u20135449.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"1950_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102832","volume":"57","author":"H Song","year":"2020","unstructured":"Song, H., et al. 2020. Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2. eBioMedicine 57: 102832.","journal-title":"eBioMedicine"},{"key":"1950_CR25","doi-asserted-by":"crossref","unstructured":"Cortes, L.M., et al.\u00a02008. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL\/6 (H-2b) and B10.RIII (H-2r) mice. Investigative Ophthalmology and Visual Science 49 (5): 1946\u20131956.","DOI":"10.1167\/iovs.07-0868"},{"issue":"11","key":"1950_CR26","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1167\/iovs.18-24630","volume":"59","author":"S Yi","year":"2018","unstructured":"Yi, S., et al. 2018. Disabled-2 (DAB2) Overexpression inhibits monocyte-derived dendritic cells\u2019 function in Vogt-Koyanagi-Harada disease. Investigative Ophthalmology & Visual Science 59 (11): 4662\u20134669.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"1950_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","volume":"41","author":"D Ross","year":"2021","unstructured":"Ross, D., and D. Siegel. 2021. The diverse functionality of NQO1 and its roles in redox control. Redox Biology 41: 101950.","journal-title":"Redox Biology"},{"issue":"3","key":"1950_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yrtph.2013.04.005","volume":"66","author":"M Yu","year":"2013","unstructured":"Yu, M., et al. 2013. Nrf2\/ARE is the potential pathway to protect Sprague-Dawley rats against oxidative stress induced by quinocetone. Regulatory Toxicology and Pharmacology 66 (3): 279\u2013285.","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"12","key":"1950_CR29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini, C., I.S. Harris, and T.W. Mak. 2013. Modulation of oxidative stress as an anticancer strategy. Nature Reviews. Drug Discovery 12 (12): 931\u2013947.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"12","key":"1950_CR30","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/0961203320950022","volume":"29","author":"P Gautam","year":"2020","unstructured":"Gautam, P., et al. 2020. Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients. Lupus 29 (12): 1544\u20131555.","journal-title":"Lupus"},{"issue":"2","key":"1950_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/1351000213Y.0000000072","volume":"19","author":"M Bozkurt","year":"2014","unstructured":"Bozkurt, M., et al. 2014. Serum prolidase enzyme activity and oxidative status in patients with Behcet\u2019s disease. Redox Report 19 (2): 59\u201364.","journal-title":"Redox Report"},{"key":"1950_CR32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","volume":"10","author":"P Leccese","year":"2019","unstructured":"Leccese, P., and E. Alpsoy. 2019. Behcet\u2019s disease: An overview of etiopathogenesis. Frontiers in Immunology 10: 1067.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1950_CR33","volume":"1868","author":"C Yu","year":"2021","unstructured":"Yu, C., et al. 2021. Astragaloside IV-induced Nrf2 nuclear translocation ameliorates lead-related cognitive impairments in mice. Biochimica et Biophysica Acta, Molecular Cell Research 1868 (1): 118853.","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"issue":"2","key":"1950_CR34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1159\/000495400","volume":"51","author":"C Tang","year":"2018","unstructured":"Tang, C., et al. 2018. 4-octyl itaconate activates Nrf2 signaling to inhibit pro-inflammatory cytokine production in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Cellular Physiology and Biochemistry 51 (2): 979\u2013990.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"1950_CR35","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L., and C. He. 2022. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Frontiers in Immunology 13: 967193.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"1950_CR36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbagen.2012.01.003","volume":"1820","author":"CA Piantadosi","year":"2012","unstructured":"Piantadosi, C.A., and H.B. Suliman. 2012. Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes. Biochimica et Biophysica Acta 1820 (4): 532\u2013541.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"1950_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena, L.A., et al. 2013. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38 (2): 225\u2013236.","journal-title":"Immunity"},{"key":"1950_CR38","volume":"12","author":"K Ohl","year":"2021","unstructured":"Ohl, K., and K. Tenbrock. 2021. Oxidative stress in SLE T cells, is NRF2 really the target to treat? Frontiers in Immunology 12: 633845.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"1950_CR39","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","volume":"120","author":"RR Caspi","year":"2010","unstructured":"Caspi, R.R. 2010. A look at autoimmunity and inflammation in the eye. The Journal of Clinical Investigation 120 (9): 3073\u20133083.","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"1950_CR40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-020-01768-7","volume":"17","author":"PC Kuo","year":"2020","unstructured":"Kuo, P.C., et al. 2020. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 17 (1): 138.","journal-title":"Journal of Neuroinflammation"},{"key":"1950_CR41","volume":"11","author":"MK Ko","year":"2020","unstructured":"Ko, M.K., et al. 2020. CD73(+) dendritic cells in cascading Th17 responses of experimental autoimmune uveitis-induced mice. Frontiers in Immunology 11: 601272.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"1950_CR42","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1167\/iovs.13-12159","volume":"54","author":"X Liu","year":"2013","unstructured":"Liu, X., et al. 2013. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet\u2019s disease. Investigative Ophthalmology & Visual Science 54 (9): 6012\u20136017.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"1950_CR43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/kes399","volume":"52","author":"F Ture-Ozdemir","year":"2013","unstructured":"Ture-Ozdemir, F., et al. 2013. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet\u2019s disease. Rheumatology (Oxford) 52 (5): 800\u2013805.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1950_CR44","first-page":"1239","volume":"23","author":"M Xu","year":"2020","unstructured":"Xu, M., et al. 2020. Dimethyl itaconate protects against lipopolysaccharide-induced endometritis by inhibition of TLR4\/NF-kappaB and activation of Nrf2\/HO-1 signaling pathway in mice. Iranian Journal of Basic Medical Sciences 23 (9): 1239\u20131244.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"1950_CR45","doi-asserted-by":"crossref","first-page":"20098","DOI":"10.1038\/srep20098","volume":"6","author":"L Li","year":"2016","unstructured":"Li, L., et al. 2016. Genetic Variations of NLR family genes in Behcet\u2019s disease. Science and Reports 6: 20098.","journal-title":"Science and Reports"},{"issue":"5","key":"1950_CR46","volume":"2","author":"S Singh","year":"2021","unstructured":"Singh, S., et al. 2021. Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection. Cell Rep Med 2 (5): 100277.","journal-title":"Cell Rep Med"},{"issue":"13","key":"1950_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109303","volume":"35","author":"KE Marks","year":"2021","unstructured":"Marks, K.E., et al. 2021. Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migration. Cell Reports 35 (13): 109303.","journal-title":"Cell Reports"},{"key":"1950_CR48","doi-asserted-by":"crossref","unstructured":"Hatscher, L., et al.\u00a02021. Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells. Science Signaling\u00a014 (680).","DOI":"10.1126\/scisignal.abe1757"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01950-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T08:13:53Z","timestamp":1717402433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01950-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1950"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01950-y","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Chongqing Medical University (2018\u2013048). All procedures were carried out in accordance with the Declaration of Helsinki. All participants signed an informed consent form at the start of the study. The animal experiments were approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}